Big Pharma Ups its Game
June 29, 2016
A video game built about the pharma industry adds marketing and malpractice capabilities
1 min read
Welcome to the June issue. Upfront features drug delivery to the placenta, an update on the French clinical trial tragedy, the futility of drug demand forecasting and more. Our cover feature takes a look at Ireland’s National Institute for Bioprocess Research and Training – NIBRT. Best Practice looks at elemental impurities derived from packaging, and the challenges of demonstrating biosimilarity, and NextGen focuses on the future of pharma manufacturing apps. We also Sit Down With Ibraheem “Ibs” Mahmood, President and Chief Executive Officer, DrugDev.
June 29, 2016
A video game built about the pharma industry adds marketing and malpractice capabilities
1 min read
June 29, 2016
Ireland can boast of many success stories when it comes to biopharma investment. Here, Barry Heavey from IDA takes us on a tour of recent investments and explains why talent and training are key.
1 min read
June 29, 2016
The UK votes to leave the European Union: what happens next, and what are the implications for pharma?
1 min read
June 27, 2016
When an industry grows rapidly, innovative approaches are required to ensure sustainable growth. Here, we speak to leaders at Ireland’s National Institute for Bioprocess Research and Training – NIBRT – to find out how a focus on talent, training and technology is changing the face of the field.
1 min read
June 27, 2016
After finally breaking into the US market, biosimilars have created a real buzz in the industry, but the best practice for demonstrating similarity can be daunting to say the least.
1 min read
June 27, 2016
Packaging components can leach into drug products and become foreign impurities. Guidelines exist for the testing of drug products for elemental impurities, but how are these applied to elemental impurities derived from drug product packaging?
1 min read
June 24, 2016
When it comes to film coating, there’s more than meets the eye. Is the drug or tablet core sensitive to acidity or moisture? What release profile is needed? And finally, how will the patient react to the finished product?
1 min read
June 24, 2016
Few oral biologics have made it to market, and though the challenges are well known, the benefits are huge and the task is not impossible. New technologies can help.
1 min read
June 24, 2016
Sitting Down With... Ibraheem “Ibs” Mahmood, President and Chief Executive Officer, DrugDev, founded in the UK and headquartered in King of Prussia, PA, USA.
1 min read
June 24, 2016
Manufacturers have gotten to grips with the complexities of batch-based bioprocesses, but breaking into the realm of continuous bioprocessing can lead to even greater efficiency.
1 min read
June 24, 2016
Decisions around toxicology testing must be made using scientific methods, not emotions or politics.
1 min read
June 24, 2016
Europe has set the stage for safer supply chains with its Falsified Medicines Directive. Next, the spotlight could fall on using serialization to boost patient centricity.
1 min read
June 24, 2016
Amazing innovation is happening all around us in the pharma industry. We should take the time to look outside of our own unique areas to congratulate the efforts of others.
1 min read
June 24, 2016
Will future drugs in Europe be priced based on therapeutic outcomes?
1 min read
June 24, 2016
Will expanding the Priority Review Voucher scheme defeat its original purpose?
1 min read
June 24, 2016
How difficult is it to develop a new drug? Statistics have the answer
1 min read
June 24, 2016
The EMA says it will review its standards for first-in-human trials
1 min read
June 24, 2016
A survey-based report highlights wildly inaccurate drug demand projections
1 min read
June 24, 2016
Tumor cells and phages inspire a new drug delivery method targeting the placenta
1 min read
June 23, 2016
Cell therapy successes are widely hailed as breakthroughs, but will adverse effects and patient deaths hold the field back?
1 min read
False
False